Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Gene linked to aggressive 'wet' age-related macular degeneration
Slashdot It! Slashdot Gene linked to aggressive 'wet' age-related macular degeneration
Submit to Reddit Submit Gene linked to aggressive 'wet' age-related macular degeneration to Reddit
Reading: Gene linked to aggressive 'wet' age-related macular degenerationTwitter This Reading: Gene linked to aggressive 'wet' age-related macular degenerationTwitter Gene linked to aggressive 'wet' age-related macular degeneration
Add to Facebook Add Gene linked to aggressive 'wet' age-related macular degeneration to Facebook

Gene linked to aggressive 'wet' age-related macular degeneration

November 27, 2006

A gene variant that increases the risk of developing the aggressive "wet" form of age-related macular degeneration (AMD), the most common cause of blindness in people over age 50, is reported in two recent articles in Science by researchers at Yale School of Medicine.

AMD causes light-sensitive cells in the retina to break down, resulting in progressive loss of central vision. Of the two forms of AMD, the "dry" is more common than the "wet" form. Wet macular degeneration can rapidly lead to blindness, while the dry AMD progresses more slowly.




Last year, Josephine Hoh, associate professor in the Departments of Epidemiology & Public Health and Ophthalmology at Yale and senior author on one of the two new studies, identified a gene for dry AMD and found that both wet and dry AMD are associated with a variant in the complement factor H (CFH) gene on chromosome 1.

Hoh now reports they have found a single nucleotide polymorphism (SNP)-a one-base change in the sequence-of the regulatory part of the HTRA1 gene on chromosome 10 that leads to greatly increased risk of developing the wet form of AMD.

According to Hoh, buildup of abnormal blood vessels in Caucasian patients is compounded by development of large waste deposits called drusen. Chinese patients, she said, develop little to no drusen and progress directly to wet AMD. This study demonstrates that these two major genes, CFH and HTRA1, in two different biological pathways, each affect the risk for a distinct component of the AMD phenotype: CFH influences the drusen of dry AMD, whereas HTRA1 influences blood vessel development, the hallmark of the wet disease type. When the two processes are combined, it leads to the composite characteristics that are seen in some cases of AMD.

Hoh, her collaborators in Hong Kong, and her colleagues at Yale including Michael Snyder and Colin Barnstable in the Departments of Molecular, Cellular and Developmental Biology and Molecular Biophysics and Biochemistry, and Ophthalmology, did trans-racial gene mapping by comparing genomes between precisely defined populations to find the incidence of SNP in a Chinese population-96 with AMD and 130 with normal vision.

"We found that patients with the HTRA1 SNP were 10 times more likely to have wet AMD than those without this gene variant," said Hoh. "While this is only preliminary work, it points to possible directions for future treatment of wet AMD."

Hoh also worked on a replication study led by Kang Zhang at the University of Utah School of Medicine that found a link between the same SNP and AMD. Zhang and his team studied 581 Caucasian patients with AMD and 309 with normal vision. These patients had wet AMD as well as a large amount of drusen.

To confirm the association, the Utah team also examined several donor eyes and measured the expression of the gene and the encoded protein. They found that the expressions were elevated in the eyes of patients who carry HTRA1.

"The marker we have identified is very much associated with AMD, but no one has ever pinpointed the clinical features of the gene. We need to conduct further analysis in order to understand the biological mechanisms," said Hoh.

Yale University





Science News and Science Current Events Tag Cloud
This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size.
Tumor cell   Longevity   Aging   Nanoscale   Gravitational Wave   Stem cells   Radiotherapy   Ace Inhibitors   Antimicrobial   Influenza   Schizophrenia   Behavioral Problems   Diabetes   Bone Density   Crohn's Disease   Endangered Species   Biodiesel   Marine Species   Ebola   Polycystic kidney disease   Melanoma   Huntingtons Disease   Birth Defects   Brain function   Progesterone  
Related Macular Degeneration Current Events and Macular Degeneration News Articles Macular Degeneration Current Events and Macular Degeneration News RSS Macular Degeneration Current Events and Macular Degeneration News RSS
'Nature' and 'nurture' variables early predictors of AMD
Like many diseases, causes for age-related macular degeneration (AMD) can be categorized as either "nature" or "nurture".

Structures from the human immune system's oldest branch shed light on a range of diseases
How molecules of the oldest branch of the human immune system have interconnected has remained a mystery.

Omega-3 fatty acids appear to impact AMD progression
Omega-3 fatty acids found in fatty fish such as tuna and salmon may protect against progression of age-related macular degeneration (AMD), but the benefits appear to depend on the stage of disease and whether certain supplements are taken.

Major Breakthrough in Early Detection and Prevention of AMD
A team of researchers led by Dr. Jayakrishna Ambati at the University of Kentucky has discovered a biological marker for neovascular age-related macular degeneration (AMD), the leading cause of blindness in older adults.

UNC study suggests new approach to common cause of blindness
Researchers at the University of North Carolina at Chapel Hill School of Medicine in collaboration with lead investigators at the University of Kentucky have identified a new target for the diagnosis and treatment of age-related macular degeneration, the most common cause of blindness in older Americans.

Why do people with Down syndrome have less cancer?
Most cancers are rare in people with Down syndrome, whose overall cancer mortality is below 10 percent of that in the general population.

Erectile dysfunction treatments do not appear to damage vision over 6 months
Two medications used to treat erectile dysfunction in men (tadalafil and sildenafil) do not appear to have visual side effects when taken daily for six months, despite concerns about eye-related complications.

Growth factor TGF-B helps maintain health of retinal blood vessels
Scientists at Schepens Eye Research Institute have found that the growth factor known as TGF-β is essential to the health of blood vessels in the retina and that blocking it can cause retinal dysfunction.

Ambati study published in PNAS
The side effects of an experimental "gene-silencing" treatment that is currently being investigated for a variety of diseases are even more wide-ranging than previously discovered, according to a study by a University of Kentucky researcher.

Mutated gene in zebrafish sheds light on blindness in humans
Among zebrafish, the eyes have it. Inside them is a mosaic of light-sensitive cells whose structure and functions are nearly identical to those of humans.
More Macular Degeneration Current Events and Macular Degeneration News Articles
Macular Degeneration: The Complete Guide to Saving and Maximizing Your Sight

Macular Degeneration: The Complete Guide to Saving and Maximizing Your Sight
by Lylas G. Mogk (Author), Marja Mogk (Author)

The acclaimed book on macular degeneration—now completely revised and updated with cutting edge research and the latest developments in the field.

More than fifteen million Americans have age-related macular degeneration (AMD), and the disease will strike 200,000 more people this year. It is the most prevalent cause of vision loss in the western world. Dr. Lylas Mogk, the founding director of the Visual Rehabilitation and Research Center of the Henry Ford Health System, has a unique professional and personal understanding of AMD. A doctor and loving daughter of a parent with this frightening though manageable condition, Mogk here explains exactly what it is and how to limit its effect on your life. Reassuring and comprehensive—complete with illuminating first person stories of...

The Santa Fe Eye Protocol: A Pioneering Treatment to Reverse the Vision Loss of Age-Related Macular Degeneration and Related Retinal Conditions

The Santa Fe Eye Protocol: A Pioneering Treatment to Reverse the Vision Loss of Age-Related Macular Degeneration and Related Retinal Conditions
Starring: Alston C. Lundgren

The Santa Fe Eye Protocol is a procedure Alston C. Lundgren, MD developed to treat age-related macular degeneration (AMD). AMD is a condition that creates vision loss and leads to blindness. According to the American Macular Degeneration Foundation, AMD affects more than ten million Americans. His DVD, The Santa Fe Eye Protocol: A Pioneering Treatment to Reverse the Vision Loss of Age-Related Macular Degeneration and Related Retinal Conditions, covers the following topics: an explanation of the pathology of AMD, conventional treatments for AMD, Dr. Lundgren's acupuncture-based Protocol, the science of the Santa Fe Eye Protocol and measured results collected by Dr. Lundgren and his staff, quotes from patient testimonials, Dr. Lundgren's credentials and publications. As of September 2008,...

Conquering Macular Degeneration: The Latest Breakthroughs and Treatments

Conquering Macular Degeneration: The Latest Breakthroughs and Treatments
by Trafford Publishing

Macular degenertaion is the leading cause of blindness for those over the age of 65 and affects as many as 15 million North Americans. That number is projected to grow to an epidemic 30 million by 2010. "Getting old and going blind is not your only option! What most eye doctors are telling their patients is that there is no treatment for this disease... and that simply isn't true." These controversial words come from one of the nation's leading authorities on eye disease, Dr. Edward L. Paul, Jr.

This ground breaking book discloses the latest breakthroughs and treatments for macular degeneration. Debunking the myths that surround this blinding disease, Dr. Paul discusses new research evolving in the field of nutrition as well as cutting edge therapies in electro medicine such as...

The First Year: Age-Related Macular Degeneration: An Essential Guide for the Newly Diagnosed

The First Year: Age-Related Macular Degeneration: An Essential Guide for the Newly Diagnosed
by Daniel L. Roberts (Author)

Age-related macular degeneration (AMD) is a progressive disease of the retina wherein the light-sensing cells in the central area of vision (the macula) stop working and eventually die. AMD is the leading cause of legal blindness in people over 50. From the moment of his own diagnosis, educator and musician Dan Roberts has made it his mission to provide the most up-to-date information about AMD, its effects and challenges, through his website. Receiving over 60,000 unique visitors monthly, Roberts's site is the go-to for all things AMD. Now, as a "patient-expert," Roberts applies his wealth of knowledge to the First Year series, providing crucial information for the newly diagnosed, including cutting edge therapies, and tips on how to navigate everyday tasks with diminishing eyesight. The...

VisiVite iDefense Green Macular Degeneration Formula

VisiVite iDefense Green Macular Degeneration Formula
by Vitamin Science Inc

VisiVite® i-DefenseTM Green Formula is the most powerful macular degeneration supplement available for patients with smoking histories. It contains 15mg FloraGLO® brand Lutein, Anti-Oxidants, Zinc and 4.75mg ZeaVision® brand Zeaxanthin to promote retinal h

Macular Degeneration Awareness Ribbon Mouse Pad

Macular Degeneration Awareness Ribbon Mouse Pad
by MyHeritageWear.com

The Macular Degeneration Ribbon proudly displayed on a mouse pad. There is no better way to achieve awareness for the meaning of the Macular Degeneration Ribbon than to display it on your mouse pad for everyone to see. The mouse pad measures at 9.25 x 7.75, it is machine washable, and the colors will not fade or run. Start gaining awareness today by presenting your Macular Degeneration Ribbon mouse pad at work or at home. It is certain to keep your mouse rolling in style all while gaining support and awareness!

Age-Related Macular Degeneration: Diagnosis

Age-Related Macular Degeneration: Diagnosis
by GeneEd E-Learning

Age-related macular degeneration (AMD) leads to dysfunction of the central retina. Associated with a wide spectrum of signs and symptoms, it is the primary cause of visual disability among adults in Western societies. This course discusses the physical symptoms of both wet and dry AMD and describes the diagnostic tests used in a clinical setting, including physical examination of the retina, fundus photography, fluorescein angiography, indocyanine green angiography, and optical coherence tomography. It also provides a self-test for AMD and presents simulated images as they would be seen by a patient with AMD. eTextBooks from GeneEd are self-paced, multimedia courses designed for nurses (RNs), doctors (MDs and PhDs), clinical research associates (CRAs and monitors), clinical research...

Macular Degeneration: A Complete Guide for Patients and Their Families

Macular Degeneration: A Complete Guide for Patients and Their Families
by Michael A. Samuel (Author)

For people who start losing their vision to macular degeneration, the prospect of impending blindness is frightening and terribly depressing. They often get contradictory advice about surgery, medical treatments, natural supplements, and lifestyle changes that might arrest or reverse the condition, and these conflicting recommendations only compound their anxiety.

Finally, in Macular Degeneration: A Complete Guide for Patients and Their Families, patients and their loved ones can turn to one easy-to-understand and authoritative source for up-to-date information about macular degeneration. Written by renowned ophthalmologist Michael Samuel, M.D., a retinal specialist, this book casts the spotlight on macular degeneration and dispels the myths surrounding this...

Source Naturals Lutein, 20 mg, Capsules, 60 capsules

Source Naturals Lutein, 20 mg, Capsules, 60 capsules
by Source Naturals

Dietary supplement. Antioxidant carotenoid. Lutein is a potent antioxidant carotenoid found in abundance in fruits and green leafy vegetables. Lutein is also one of the dominant pigments found in the macular region of the retina in the eye. In the macula, lutein is selectively accumulated from plasma and filters out visible blue light. Recent studies suggest this filtering process serves to protect the retina from photic damage or other oxidative damage. (These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.) Lutein is extracted from the marigold flower and purified by an exclusive patented process. Contains no yeast, dairy, egg, gluten or wheat. Contains no salt, preservatives or...

Fitovers Eyewear Small Glides Sunglasses (Tortoiseshell, PDX Amber)

Fitovers Eyewear Small Glides Sunglasses (Tortoiseshell, PDX Amber)
by Fitovers

The Sm Glides Fitover with Grey PDX lenses is designed to be worn over large prescription eyewear frame shapes. These lenses maintain true color definition in all conditions are ideal for driving or any general purpose outdoor activity where annoying glare is present.

© 2009 BrightSurf.com